Source: Virtual Congress 2020 – Clinical data and COPD management
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
G. Drivas (Athens, Greece), G. Hillas (Athens, Greece), A. Papaporfyriou (Athens, Greece), M. Kaponi (Athens, Greece), K. Dimakou (Athens, Greece). PROMS and FEV1 as predictors of AECOPD. 1002

Member's Comments

No comment yet.

Related content which might interest you: Rate of FEV1 decline by FEV1 percent predicted in UPLIFT® and TIOSPIR® Source: International Congress 2016 – Pharmacological management of COPD Year: 2016 Comparison of spirometric z-scores with FEV1 percent prediction in predicting exacerbations in elderly COPD patients Source: International Congress 2016 – In-patient and out-patient COPD management Year: 2016 Are 6MWD and FEV1 the most clinically relevant measures? Source: Annual Congress 2012 - Life's a gas: aspects of respiratory gas exchange Year: 2012 Change in clinical COPD questionnaire (CCQ) symptoms domain score and FEV1 predict treatment failure during hospitalisation due to COPD exacerbations Source: Eur Respir J 2007; 30: Suppl. 51, 525s Year: 2007 Mortality predictive variables in the short-term before a COPD exacerbation Source: Eur Respir J 2006; 28: Suppl. 50, 177s Year: 2006 Tiotropium: COPD exacerbations and decline in FEV1 Source: Eur Respir J 2001; 18: Suppl. 33, 486s Year: 2001 Spirometric changes in bronchodilation tests as predictors of asthma diagnosis and treatment response in patients with FEV1 =80% predicted Source: Virtual Congress 2021 – Advances in asthma treatment Year: 2021 BODE index as predictor of exacerbation occurrence in ambulatory patients with COPD Source: Annual Congress 2007 - Exacerbations of COPD Year: 2007 FEV1/Height2 could be a better alternative than FEV1 in predicting all cause mortality in patients with COPD Source: Annual Congress 2008 - COPD - clinical and epidemiological aspects Year: 2008 NIMV in the treatment of COPD exacerbations: predictors of success Source: Eur Respir J 2004; 24: Suppl. 48, 312s Year: 2004 Does an acute FEV1 response predict long-term improvements with bronchodilators in patients with COPD? Source: Eur Respir J 2001; 18: Suppl. 33, 486s Year: 2001 Patterns of bronchodilator reversibility of FEV1 in asthma and COPD patients Source: Annual Congress 2012 - Translational respiratory medicine in asthma and COPD Year: 2012 Decline in FEV1 is faster with frequent exacerbations of COPD Source: Eur Respir J 2001; 18: Suppl. 33, 153s Year: 2001 Closing volume predicts the FEV1 response to bronchodilators in patients with COPD Source: Virtual Congress 2020 – Advances in lung function testing Year: 2020 Minimal clinically important difference and predictive validity of the mMRC and mBorg in acute exacerbations of COPD Source: International Congress 2017 – Assessing functional outcomes in chronic respiratory disease Year: 2017 Sniff nasal inspiratory pressure as a predictor of 1-year mortality after exacerbation of COPD Source: Virtual Congress 2020 – Muscle, exercise capacity and symptoms of chronic lung disease: a physio update Year: 2020 Correlation of various parameters with FEV1 in the assessment of asthma severity Source: Eur Respir J 2001; 18: Suppl. 33, 51s Year: 2001 Walking distance is a predictor of exacerbations in patients with COPD Source: Eur Respir J 2004; 24: Suppl. 48, 633s Year: 2004 Biomarkers to predict FEV1 decline in smokers and early-onset COPD. Source: Virtual Congress 2020 – Intercellular communication in tissue remodelling of chronic lung diseases Year: 2020 Lung function values as predictors for outcome during non-invasive ventilation in COPD patients Source: Annual Congress 2011 - New evidence in home mechanical ventilation Year: 2011